Frost & Sullivan today announced that Accuray Incorporated, a global leader in the field of robotic radiosurgery, is the recipient of its 2006 Award for Excellence in Technology in the field of autonomous medical robotics. Accuray was presented the award for having designed and developed the CyberKnife(R) Robotic Radiosurgery System, the world's first intelligent robotic radiosurgery system that is designed to treat tumors anywhere in the body typically with sub-millimeter accuracy. With its autonomous robotic ability to track, detect and correct for tumor and patient movement throughout the treatment, the CyberKnife System gives clinicians a more effective and accurate treatment alternative. It has been used to treat tumors on or near the spine and in the lung, liver, prostate and pancreas. The CyberKnife System delivers high-dose radiation to the tumor from many different directions, enabling physicians to treat tumors while minimizing damage to surrounding healthy tissue.
Frost & Sullivan's Excellence in Technology Award is bestowed on a company that has pioneered the development and introduction of an innovative technology. The award recognizes the company's successful development of technology, overall technical excellence and commitment to innovation.
"Accuray has distinguished itself by pioneering the development of a unique robotic radiosurgery system designed to treat tumors anywhere in the body," said Mahaneeya Raman, Research Analyst at Frost & Sullivan who identified this breakthrough technology as part of her research on Autonomous Robots. "The CyberKnife System delivers treatment alternatives to patients who may be considered medically inoperable or who are unable to withstand conventional treatment methods."
About Accuray
Accuray Incorporated, a privately held company based in Sunnyvale, Calif., is a leader in the field of robotic radiosurgery. Its CyberKnife System is the world's first and only commercially available intelligent robotic radiosurgery system designed to treat tumors anywhere in the body, typically with sub-millimeter accuracy. To date, it is estimated that the CyberKnife System has treated more than 20,000 patients worldwide. For more information, please visit http://www.accuray.com.